ro glp 1 tracker Ro's Supply Helps Patients Locate In-Demand GLP-1 Drugs Amid Shortages Ro Launches GLP-1 Insurance Coverage

Low-dose metformin exposure causes changes in expression of endocrine disruption-associated genes

It allows us to review some concepts related to the early onset of fluid retention with oral minoxidil treatment

Weight-based discrimination in employment: psychological and legal aspects

Medicare Obesity Coverage Expansion (Regulatory): The Centers for Medicare & Medicaid Services (CMS) announced that beginning in April 2026, Medicare will cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities via the BALANCE Model and Section 402 demonstrations, marking a reversal of the long-standing statutory ban on weight-loss drug coverage

Abudoureyimu et al